The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases
Open accessAbstract
Protein tyrosine kinases (PTKs) coordinate a broad spectrum of cellular responses to extracellular stimuli and cell–cell interactions during development, tissue homeostasis, and responses to environmental challenges. Thus, an understanding of the regulatory mechanisms that ensure physiological PTK function and potential aberrations of these regulatory processes during diseases such as cancer are of broad interest in biology and medicine. Aside from the expected role of phospho-tyrosine phosphatases, recent studies have revealed a critical role of covalent modification of activated PTKs with ubiquitin as a critical mechanism of their negative regulation. Members of the Cbl protein family (Cbl, Cbl-b and Cbl-c in mammals) have emerged as dominant “activated PTK-selective” ubiquitin ligases. Structural, biochemical and cell biological studies have established that Cbl protein-dependent ubiquitination targets activated PTKs for degradation either by facilitating their endocytic sorting into lysosomes or by promoting their proteasomal degradation. This mechanism also targets PTK signaling intermediates that become associated with Cbl proteins in a PTK activation-dependent manner. Cellular and animal studies have established that the relatively broadly expressed mammalian Cbl family members Cbl and Cbl-b play key physiological roles, including their critical functions to prevent the transition of normal immune responses into autoimmune disease and as tumor suppressors; the latter function has received validation from human studies linking mutations in Cbl to human leukemia. These newer insights together with embryonic lethality seen in mice with a combined deletion of Cbl and Cbl-b genes suggest an unappreciated role of the Cbl family proteins, and by implication the ubiquitin-dependent control of activated PTKs, in stem/progenitor cell maintenance. Future studies of existing and emerging animal models and their various cell lineages should help test the broader implications of the evolutionarily-conserved Cbl family protein-mediated, ubiquitin-dependent, negative regulation of activated PTKs in physiology and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RING Domain E3 Ubiquitin Ligases
Deshaies, R. J., & Joazeiro, C. A. P. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.101807.093809 · Cited by 2,679
Janus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149
Ras signalling on the endoplasmic reticulum and the Golgi
Chiu, V. K., Bivona, T., Hach, A., Sajous, J. B., Silletti, J., Wiener, H., Johnson, R. L., Cox, A. D., & Philips, M. R. (2002) · Nature Cell Biology · doi:10.1038/ncb783 · Cited by 594 · cited 1×
“Additional studies have uncovered endocytic pathways that deliver active receptor signaling complexes to ER and Golgi for Ras activation [25].”
BackgroundInhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J. (2007) · Nature · doi:10.1038/nature05998 · Cited by 357
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
Berlin, I., Schwartz, H., & Nash, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016287 · Cited by 121
Hirasaka, K., Kohno, S., Goto, J., Furochi, H., Mawatari, K., Harada, N., Hosaka, T., Nakaya, Y., Ishidoh, K., Obata, T., et al. (2007) · Diabetes · doi:10.2337/db06-1768 · Cited by 69
Duan, L., Raja, S. M., Chen, G., Virmani, S., Williams, S. H., Clubb, R. J., Mukhopadhyay, C., Rainey, M. A., Ying, G., Dimri, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188086 · Cited by 49
Self-citation
Research works printed but not linked: 210
- Hunter, 2009, Tyrosine phosphorylation: thirty years and counting, Curr. Opin. Cell Biol., 21, 140, 10.1016/j.ceb.2009.01.028 · DOI · Paper page
- Weiss, 2010, The right team at the right time to go for a home run: tyrosine kinase activation by the TCR, Nat. Immunol., 11, 101, 10.1038/ni0210-101 · DOI
- Hendriks, 2008, Protein tyrosine phosphatases: functional inferences from mouse models and human diseases, FEBS J., 275, 816, 10.1111/j.1742-4658.2008.06249.x · DOI
- Julien, 2011, Inside the human cancer tyrosine phosphatome, Nat. Rev. Cancer, 11, 35, 10.1038/nrc2980 · DOI · Paper page
- Carpenter, 2000, The EGF receptor: a nexus for trafficking and signaling, Bioessays, 22, 697, 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1 · DOI · Paper page
- Waterman, 2001, Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases, FEBS Lett., 490, 142, 10.1016/S0014-5793(01)02117-2 · DOI · Paper page
- Wells, 1990, Ligand-induced transformation by a noninternalizing epidermal growth factor receptor, Science, 247, 962, 10.1126/science.2305263 · DOI · Paper page
- Hynes, 2005, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat. Rev. Cancer, 5, 341, 10.1038/nrc1609 · DOI · Paper page
- Harari, 2000, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer, Oncogene, 19, 6102, 10.1038/sj.onc.1203973 · DOI · Paper page
- McClintock, 2010, Transforming growth factor-{alpha} enhances corneal epithelial cell migration by promoting EGFR recycling, Invest. Ophthalmol. Vis. Sci., 51, 3455, 10.1167/iovs.09-4386 · DOI
- Ouyang, 1999, Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor, J. Cell. Physiol., 179, 52, 10.1002/(SICI)1097-4652(199904)179:1<52::AID-JCP7>3.0.CO;2-M · doi:10.1002/(sici)1097-4652(199904)179:1<52::aid-jcp7>3.0.co;2-m
- Roepstorff, 2009, Differential effects of EGFR ligands on endocytic sorting of the receptor, Traffic, 10, 1115, 10.1111/j.1600-0854.2009.00943.x · DOI · Paper page
- Sigismund, 2008, Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation, Dev. Cell, 15, 209, 10.1016/j.devcel.2008.06.012 · DOI · Paper page
- Di Fiore, 2001, Endocytosis and signaling. An inseparable partnership, Cell, 106, 1, 10.1016/S0092-8674(01)00428-7 · DOI · Paper page
- Barker, 2002, Retrograde signaling by the neurotrophins follows a well-worn trk, Trends Neurosci., 25, 379, 10.1016/S0166-2236(02)02199-9 · DOI
- McPherson, 2001, Signaling on the endocytic pathway, Traffic, 2, 375, 10.1034/j.1600-0854.2001.002006375.x · DOI · Paper page
- Seto, 2002, When cell biology meets development: endocytic regulation of signaling pathways, Genes Dev., 16, 1314, 10.1101/gad.989602 · DOI · Paper page
- Burke, 2001, Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking, Mol. Biol. Cell, 12, 1897, 10.1091/mbc.12.6.1897 · DOI · Paper page
- Qui, 1992, PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity, Neuron, 9, 705, 10.1016/0896-6273(92)90033-A · DOI · Paper page
- Pasic, 2011, Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue, Genes Dev., 25, 1641, 10.1101/gad.2025611 · DOI
- Vieira, 1996, Control of EGF receptor signaling by clathrin-mediated endocytosis, Science, 274, 2086, 10.1126/science.274.5295.2086 · DOI · Paper page
- Teis, 2002, Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction, Dev. Cell, 3, 803, 10.1016/S1534-5807(02)00364-7 · DOI · Paper page
- Wunderlich, 2001, A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment, J. Cell Biol., 152, 765, 10.1083/jcb.152.4.765 · DOI · Paper page
- Bild, 2002, Cytoplasmic transport of Stat3 by receptor-mediated endocytosis, EMBO J., 21, 3255, 10.1093/emboj/cdf351 · DOI
- Panopoulou, 2002, Early endosomal regulation of Smad-dependent signaling in endothelial cells, J. Biol. Chem., 277, 18046, 10.1074/jbc.M107983200 · DOI · Paper page
- Pierce, 2001, New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades, Oncogene, 20, 1532, 10.1038/sj.onc.1204184 · DOI · Paper page
- Pennock, 2003, Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling, Mol. Cell. Biol., 23, 5803, 10.1128/MCB.23.16.5803-5815.2003 · DOI
- Wang, 2002, Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival, Mol. Cell. Biol., 22, 7279, 10.1128/MCB.22.20.7279-7290.2002 · DOI · Paper page
- Wiley, 1991, The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor, J. Biol. Chem., 266, 11083, 10.1016/S0021-9258(18)99131-3 · DOI · Paper page
- Schulman, 2009, Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways, Nat. Rev. Mol. Cell Biol., 10, 319, 10.1038/nrm2673 · DOI · Paper page
- Macgurn, 2012, Ubiquitin and membrane protein turnover: from cradle to grave, Annu. Rev. Biochem., 81, 231, 10.1146/annurev-biochem-060210-093619 · DOI · Paper page
- Wegner, 2011, ESCRT proteins and cell signalling, Traffic, 12, 1291, 10.1111/j.1600-0854.2011.01210.x · DOI
- Henne, 2011, The ESCRT pathway, Dev. Cell, 21, 77, 10.1016/j.devcel.2011.05.015 · DOI · Paper page
- Babst, 2011, MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between, Curr. Opin. Cell Biol., 23, 452, 10.1016/j.ceb.2011.04.008 · DOI · Paper page
- Rusten, 2011, Shaping development with ESCRTs, Nat. Cell Biol., 14, 38, 10.1038/ncb2381 · DOI
- Shields, 2011, How ubiquitin functions with ESCRTs, Traffic, 12, 1306, 10.1111/j.1600-0854.2011.01242.x · DOI · Paper page
- Mizuno, 2005, Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes, Mol. Biol. Cell, 16, 5163, 10.1091/mbc.E05-06-0560 · DOI · Paper page
- Row, 2006, The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation, J. Biol. Chem., 281, 12618, 10.1074/jbc.M512615200 · DOI · Paper page
- Wright, 2011, Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination, Cell Biochem. Biophys., 60, 39, 10.1007/s12013-011-9181-9 · DOI
- McCullough, 2006, Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery, Curr. Biol., 16, 160, 10.1016/j.cub.2005.11.073 · DOI · Paper page
- Ma, 2007, Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation, J. Biol. Chem., 282, 9805, 10.1074/jbc.M611635200 · DOI
- Row, 2007, The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation, J. Biol. Chem., 282, 30929, 10.1074/jbc.M704009200 · DOI · Paper page
- Wu, 2004, Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8, Mol. Cell. Biol., 24, 7748, 10.1128/MCB.24.17.7748-7757.2004 · DOI · Paper page
- Meenhuis, 2011, The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor, Biochem. J., 434, 343, 10.1042/BJ20101628 · DOI
- Z. Liu, S.M. Zanata, J. Kim, M.A. Peterson, D. Di Vizio, L.R. Chirieac, S. Pyne, M. Agostini, M.R. Freeman, M. Loda, The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation, Oncogene (in press) (Epub ahead of print, Jun 18 2012). · DOI
- Pareja, 2012, Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression, Oncogene, 31, 4599, 10.1038/onc.2011.587 · DOI
- Harhaj, 2012, Regulation of NF-kappaB by deubiquitinases, Immunol. Rev., 246, 107, 10.1111/j.1600-065X.2012.01100.x · DOI · Paper page
- Lu, 2009, Degradation of activated protein kinases by ubiquitination, Annu. Rev. Biochem., 78, 435, 10.1146/annurev.biochem.013008.092711 · DOI
- Mori, 1992, Ligand-induced polyubiquitination of the platelet-derived growth factor beta-receptor, J. Biol. Chem., 267, 6429, 10.1016/S0021-9258(18)42714-7 · DOI · Paper page
- Langdon, 1989, v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas, Proc. Natl. Acad. Sci. U.S.A., 86, 1168, 10.1073/pnas.86.4.1168 · DOI · Paper page
- Blake, 1993, The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation, EMBO J., 12, 2017, 10.1002/j.1460-2075.1993.tb05851.x · DOI
- Meng, 1999, Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase, Nature, 398, 84, 10.1038/18050 · DOI · Paper page
- Zheng, 2000, Structure of a c-Cbl–UbcH7 complex: RING domain function in ubiquitin–protein ligases, Cell, 102, 533, 10.1016/S0092-8674(00)00057-X · DOI · Paper page
- Ota, 2000, The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase, J. Biol. Chem., 275, 414, 10.1074/jbc.275.1.414 · DOI
- Lill, 2000, The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor, J. Biol. Chem., 275, 367, 10.1074/jbc.275.1.367 · DOI
- Lupher, 1999, The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction, Immunol. Today, 20, 375, 10.1016/S0167-5699(99)01484-X · DOI
- Naramura, 2011, Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: insights from in vivo models, Commun. Integr. Biol., 4, 159, 10.4161/cib.4.2.14716 · DOI
- Naramura, 2011, Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders, Oncotarget, 2, 245, 10.18632/oncotarget.233 · DOI
- Duan, 2004, The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling, Immunity, 21, 7, 10.1016/j.immuni.2004.06.012 · DOI
- Thien, 2005, c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses, Biochem. J., 391, 153, 10.1042/BJ20050892 · DOI · Paper page
- Lipkowitz, 2011, RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis, Nat. Rev. Cancer, 11, 629, 10.1038/nrc3120 · DOI · Paper page
- Bartkiewicz, 1999, Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor, J. Biol. Chem., 274, 30887, 10.1074/jbc.274.43.30887 · doi:10.1074/jbc.274.43.30887
- Davies, 2004, Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b, Oncogene, 23, 7104, 10.1038/sj.onc.1207952 · DOI
- Peschard, 2007, Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b, Mol. Cell, 27, 474, 10.1016/j.molcel.2007.06.023 · DOI
- Nau, 2003, Comparative genomic organization of the cbl genes, Gene, 308, 103, 10.1016/S0378-1119(03)00471-2 · DOI
- Keane, 1999, Cbl-3: a new mammalian Cbl family protein, Oncogene, 18, 3365, 10.1038/sj.onc.1202753 · DOI
- Langenick, 2008, A Dictyostelium homologue of the metazoan Cbl proteins regulates STAT signalling, J. Cell Sci., 121, 3524, 10.1242/jcs.036798 · DOI
- Blake, 1991, The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif, Oncogene, 6, 653
- Andoniou, 1994, Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene, EMBO J., 13, 4515, 10.1002/j.1460-2075.1994.tb06773.x · DOI · Paper page
- Donovan, 1994, The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor, J. Biol. Chem., 269, 22921, 10.1016/S0021-9258(17)31595-8 · DOI · Paper page
- Reedquist, 1994, Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein, Proc. Natl. Acad. Sci. U.S.A., 91, 4135, 10.1073/pnas.91.10.4135 · DOI
- Fukazawa, 1995, The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase, J. Biol. Chem., 270, 19141, 10.1074/jbc.270.32.19141 · DOI · Paper page
- Rao, 2002, The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system, J. Leukoc. Biol., 71, 753, 10.1189/jlb.71.5.753 · DOI · Paper page
- Thien, 2001, Cbl: many adaptations to regulate protein tyrosine kinases, Nat. Rev. Mol. Cell Biol., 2, 294, 10.1038/35067100 · DOI · Paper page
- Tsygankov, 2001, Beyond the RING: CBL proteins as multivalent adapters, Oncogene, 20, 6382, 10.1038/sj.onc.1204781 · DOI
- Fukazawa, 1996, Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins, J. Biol. Chem., 271, 14554, 10.1074/jbc.271.24.14554 · DOI · Paper page
- Panchamoorthy, 1996, p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase, J. Biol. Chem., 271, 3187, 10.1074/jbc.271.6.3187 · DOI · Paper page
- Bonita, 1997, Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity, Mol. Cell. Biol., 17, 4597, 10.1128/MCB.17.8.4597 · DOI
- Meisner, 1995, Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells, Mol. Cell. Biol., 15, 3571, 10.1128/MCB.15.7.3571 · DOI · Paper page
- Yoon, 1995, Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl, Science, 269, 1102, 10.1126/science.7652556 · DOI · Paper page
- Lupher, 1996, A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells, J. Biol. Chem., 271, 24063, 10.1074/jbc.271.39.24063 · DOI · Paper page
- Lupher, 1998, Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323, J. Biol. Chem., 273, 35273, 10.1074/jbc.273.52.35273 · DOI · Paper page
- Lupher, 1997, The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70, J. Biol. Chem., 272, 33140, 10.1074/jbc.272.52.33140 · DOI · Paper page
- Miyake, 1999, Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain, J. Biol. Chem., 274, 16619, 10.1074/jbc.274.23.16619 · DOI · Paper page
- Thien, 1997, Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl, Oncogene, 15, 2909, 10.1038/sj.onc.1201468 · DOI
- Miyake, 1998, The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha, Proc. Natl. Acad. Sci. U.S.A., 95, 7927, 10.1073/pnas.95.14.7927 · DOI · Paper page
- Hicke, 1996, Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis, Cell, 84, 277, 10.1016/S0092-8674(00)80982-4 · DOI · Paper page
- Terrell, 1998, A function for monoubiquitination in the internalization of a G protein-coupled receptor, Mol. Cell, 1, 193, 10.1016/S1097-2765(00)80020-9 · DOI · Paper page
- Abella, 2005, Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation, Mol. Cell. Biol., 25, 9632, 10.1128/MCB.25.21.9632-9645.2005 · DOI · Paper page
- Lee, 1999, The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation, EMBO J., 18, 3616, 10.1093/emboj/18.13.3616 · DOI · Paper page
- Peschard, 2001, Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein, Mol. Cell, 8, 995, 10.1016/S1097-2765(01)00378-1 · DOI · Paper page
- Rao, 2002, An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn, Signal Transduct., 2, 29, 10.1002/1615-4061(200205)2:1/2<29::AID-SITA29>3.0.CO;2-7 · doi:10.1002/1615-4061(200205)2:1/2<29::aid-sita29>3.0.co;2-7
- Rao, 2001, The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation, EMBO J., 20, 7085, 10.1093/emboj/20.24.7085 · DOI
- Rao, 2002, Negative regulation of Lck by Cbl ubiquitin ligase, Proc. Natl. Acad. Sci. U.S.A., 99, 3794, 10.1073/pnas.062055999 · DOI
- Rao, 2000, The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells, J. Immunol., 164, 4616, 10.4049/jimmunol.164.9.4616 · DOI
- Joazeiro, 1999, The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin–protein ligase, Science, 286, 309, 10.1126/science.286.5438.309 · DOI · Paper page
- Levkowitz, 1999, Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1, Mol. Cell, 4, 1029, 10.1016/S1097-2765(00)80231-2 · DOI · Paper page
- Ettenberg, 2001, Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex, J. Biol. Chem., 276, 27677, 10.1074/jbc.M102641200 · DOI · Paper page
- Kim, 2004, Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation, Oncogene, 23, 1645, 10.1038/sj.onc.1207298 · DOI
- Ryan, 2010, The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme, J. Biol. Chem., 285, 23687, 10.1074/jbc.M109.091157 · DOI
- Kales, 2012, Cbl exposes its RING finger, Nat. Struct. Mol. Biol., 19, 131, 10.1038/nsmb.2241 · DOI
- Ng, 2008, Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates, EMBO J., 27, 804, 10.1038/emboj.2008.18 · DOI
- Penengo, 2003, c-Cbl is a critical modulator of the Ron tyrosine kinase receptor, Oncogene, 22, 3669, 10.1038/sj.onc.1206585 · doi:10.1038/sj.onc.1206585
- Peschard, 2004, A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation, J. Biol. Chem., 279, 29565, 10.1074/jbc.M403954200 · DOI
- Hu, 2005, Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins, J. Biol. Chem., 280, 18943, 10.1074/jbc.M414157200 · DOI
- Masson, 2006, Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation, Biochem. J., 399, 59, 10.1042/BJ20060464 · DOI
- Wu, 2003, Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase, Mol. Cell, 11, 1445, 10.1016/S1097-2765(03)00234-X · DOI · Paper page
- Thien, 2001, RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation, Mol. Cell, 7, 355, 10.1016/S1097-2765(01)00183-6 · DOI · Paper page
- Kobashigawa, 2011, Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b, Proc. Natl. Acad. Sci. U.S.A., 108, 20579, 10.1073/pnas.1110712108 · DOI
- Dou, 2012, Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl, Nat. Struct. Mol. Biol., 19, 184, 10.1038/nsmb.2231 · DOI · Paper page
- Schmidt, 2003, Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization, Proc. Natl. Acad. Sci. U.S.A., 100, 6505, 10.1073/pnas.1031790100 · DOI · Paper page
- Ghosh, 2004, Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase, J. Biol. Chem., 279, 36132, 10.1074/jbc.M404189200 · DOI
- Kassenbrock, 2004, Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations, J. Biol. Chem., 279, 28017, 10.1074/jbc.M404114200 · DOI
- Rosenkranz, 2000, Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression, J. Biol. Chem., 275, 9620, 10.1074/jbc.275.13.9620 · DOI
- Liu, 2002, Cbl and Cbl-b in T-cell regulation, Trends Immunol., 23, 140, 10.1016/S1471-4906(01)02157-3 · DOI
- Miura-Shimura, 2003, Cbl-mediated ubiquitinylation and negative regulation of Vav, J. Biol. Chem., 278, 38495, 10.1074/jbc.M305656200 · DOI
- Zhang, 2003, Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b, J. Biol. Chem., 278, 23978, 10.1074/jbc.M212671200 · DOI
- d'Azzo, 2005, E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation, Traffic, 6, 429, 10.1111/j.1600-0854.2005.00294.x · DOI · Paper page
- Haglund, 2003, Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation, Nat. Cell Biol., 5, 461, 10.1038/ncb983 · DOI · Paper page
- Levkowitz, 1998, c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor, Genes Dev., 12, 3663, 10.1101/gad.12.23.3663 · DOI · Paper page
- Umebayashi, 2008, Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation, Mol. Biol. Cell, 19, 3454, 10.1091/mbc.E07-10-0988 · DOI
- Fasen, 2008, Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway, Traffic, 9, 251, 10.1111/j.1600-0854.2007.00679.x · DOI
- Huang, 2006, Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain, Mol. Cell, 21, 737, 10.1016/j.molcel.2006.02.018 · DOI · Paper page
- Longva, 2002, Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies, J. Cell Biol., 156, 843, 10.1083/jcb.200106056 · DOI · Paper page
- Huang, 2010, Roles of E3 ubiquitin ligases in cell adhesion and migration, Cell Adh. Migr., 4, 10, 10.4161/cam.4.1.9834 · DOI
- Ryan, 2006, Regulating the regulator: negative regulation of Cbl ubiquitin ligases, Trends Biochem. Sci., 31, 79, 10.1016/j.tibs.2005.12.004 · DOI
- Soubeyran, 2002, Cbl-CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors, Nature, 416, 183, 10.1038/416183a · DOI · Paper page
- Petrelli, 2002, The endophilin–CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met, Nature, 416, 187, 10.1038/416187a · DOI · Paper page
- Duan, 2003, Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis, J. Biol. Chem., 278, 28950, 10.1074/jbc.M304474200 · DOI · Paper page
- Khan, 2006, Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking, J. Biol. Chem., 281, 14486, 10.1074/jbc.M509332200 · DOI · Paper page
- Huang, 2007, EGF receptor ubiquitination is not necessary for its internalization, Proc. Natl. Acad. Sci. U.S.A., 104, 16904, 10.1073/pnas.0707416104 · DOI · Paper page
- Goh, 2010, Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor, J. Cell Biol., 189, 871, 10.1083/jcb.201001008 · DOI · Paper page
- Swaminathan, 2006, The Cbl family proteins: ring leaders in regulation of cell signaling, J. Cell. Physiol., 209, 21, 10.1002/jcp.20694 · DOI · Paper page
- Miura, 2003, Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes, Biochemistry, 42, 14335, 10.1021/bi034808i · DOI
- Standaert, 2004, Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes, Biochemistry, 43, 15494, 10.1021/bi049222q · DOI
- Goh, 2002, c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription, Endocrinology, 143, 3590, 10.1210/en.2002-220374 · doi:10.1210/en.2002-220374
- Wang, 2002, Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation, Oncogene, 21, 5346, 10.1038/sj.onc.1205670 · DOI
- Timpson, 2005, Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor, Cancer Res., 65, 3273, 10.1158/0008-5472.CAN-04-2118 · DOI
- Fong, 2003, Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function, J. Biol. Chem., 278, 33456, 10.1074/jbc.M301317200 · DOI
- Wong, 2002, Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling, EMBO J., 21, 4796, 10.1093/emboj/cdf493 · DOI · Paper page
- Wong, 2006, Regulator of epidermal growth factor signaling: Sprouty, Methods Mol. Biol., 327, 61
- Wiedemann, 2005, T-cell activation is accompanied by an ubiquitination process occurring at the immunological synapse, Immunol. Lett., 98, 57, 10.1016/j.imlet.2004.10.014 · DOI
- Naramura, 2002, c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation, Nat. Immunol., 3, 1192, 10.1038/ni855 · DOI · Paper page
- Rathinam, 2008, The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells, Genes Dev., 22, 992, 10.1101/gad.1651408 · DOI
- Rathinam, 2010, Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling, Cancer Cell, 18, 341, 10.1016/j.ccr.2010.09.008 · DOI
- Naramura, 2010, Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells, Proc. Natl. Acad. Sci. U.S.A., 107, 16274, 10.1073/pnas.1007575107 · DOI
- Ledda, 2007, Negative regulation of receptor tyrosine kinase (RTK) signaling: a developing field, Biomark. Insights, 2, 45, 10.1177/117727190700200029 · DOI
- Segatto, 2011, Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors, J. Cell Sci., 124, 1785, 10.1242/jcs.083303 · DOI
- Ahmed, 2008, Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth, J. Natl. Cancer Inst., 100, 1606, 10.1093/jnci/djn365 · DOI
- Gur, 2004, LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation, EMBO J., 23, 3270, 10.1038/sj.emboj.7600342 · DOI · Paper page
- Frosi, 2010, A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation, J. Cell Biol., 189, 557, 10.1083/jcb.201002032 · DOI · Paper page
- Schmid, 2007, Integrating molecular and network biology to decode endocytosis, Nature, 448, 883, 10.1038/nature06031 · DOI · Paper page
- Nicholson, 2005, Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling, Proc. Natl. Acad. Sci. U.S.A., 102, 2328, 10.1073/pnas.0409675102 · DOI
- Kario, 2005, Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling, J. Biol. Chem., 280, 7038, 10.1074/jbc.M408575200 · DOI
- Tanaka, 2008, c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130, Mol. Cell. Biol., 28, 4805, 10.1128/MCB.01784-07 · DOI
- Tarcic, 2009, An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis, Curr. Biol., 19, 1788, 10.1016/j.cub.2009.09.048 · DOI
- Guy, 2009, Sprouty proteins: modified modulators, matchmakers or missing links?, J. Endocrinol., 203, 191, 10.1677/JOE-09-0110 · DOI
- Hanafusa, 2002, Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway, Nat. Cell Biol., 4, 850, 10.1038/ncb867 · DOI · Paper page
- Sasaki, 2003, Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1, Nat. Cell Biol., 5, 427, 10.1038/ncb978 · DOI · Paper page
- Wong, 2001, Evidence for direct interaction between Sprouty and Cbl, J. Biol. Chem., 276, 5866, 10.1074/jbc.M006945200 · DOI
- Hall, 2003, hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl, Curr. Biol., 13, 308, 10.1016/S0960-9822(03)00086-1 · DOI
- Rubin, 2003, Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops, Curr. Biol., 13, 297, 10.1016/S0960-9822(03)00053-8 · DOI · Paper page
- Egan, 2002, The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins, Proc. Natl. Acad. Sci. U.S.A., 99, 6041, 10.1073/pnas.052090899 · DOI
- Choi, 2006, Dual effects of Sprouty1 on TCR signaling depending on the differentiation state of the T cell, J. Immunol., 176, 6034, 10.4049/jimmunol.176.10.6034 · DOI
- Meisner, 1997, Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development, Mol. Cell. Biol., 17, 2217, 10.1128/MCB.17.4.2217 · DOI
- Pai, 2000, D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis, Cell, 103, 51, 10.1016/S0092-8674(00)00104-5 · DOI
- Nowak, 2011, Interpretation of the FGF8 morphogen gradient is regulated by endocytic trafficking, Nat. Cell Biol., 13, 153, 10.1038/ncb2155 · DOI
- Murphy, 1998, Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice, Mol. Cell. Biol., 18, 4872, 10.1128/MCB.18.8.4872 · DOI · Paper page
- Naramura, 1998, Altered thymic positive selection and intracellular signals in Cbl-deficient mice, Proc. Natl. Acad. Sci. U.S.A., 95, 15547, 10.1073/pnas.95.26.15547 · DOI · Paper page
- El Chami, 2005, Androgen-dependent apoptosis in male germ cells is regulated through the proto-oncoprotein Cbl, J. Cell Biol., 171, 651, 10.1083/jcb.200507076 · DOI
- Molero, 2004, c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action, J. Clin. Invest., 114, 1326, 10.1172/JCI21480 · DOI
- Bachmaier, 2000, Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b, Nature, 403, 211, 10.1038/35003228 · DOI · Paper page
- Chiang, 2000, Cbl-b regulates the CD28 dependence of T-cell activation, Nature, 403, 216, 10.1038/35003235 · DOI · Paper page
- Nakao, 2009, Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading, Mol. Cell. Biol., 29, 4798, 10.1128/MCB.01347-08 · DOI · Paper page
- Griffiths, 2003, Cbl-3-deficient mice exhibit normal epithelial development, Mol. Cell. Biol., 23, 7708, 10.1128/MCB.23.21.7708-7718.2003 · DOI
- Langdon, 1989, The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein, J. Virol., 63, 5420, 10.1128/JVI.63.12.5420-5424.1989 · DOI
- Kitaura, 2007, Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b, Immunity, 26, 567, 10.1016/j.immuni.2007.03.015 · DOI
- Sargin, 2007, Flt3-dependent transformation by inactivating c-Cbl mutations in AML, Blood, 110, 1004, 10.1182/blood-2007-01-066076 · DOI · Paper page
- Caligiuri, 2007, Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia, Blood, 110, 1022, 10.1182/blood-2006-12-061176 · DOI
- Makishima, 2009, Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies, J. Clin. Oncol., 27, 6109, 10.1200/JCO.2009.23.7503 · DOI · Paper page
- Brecqueville, 2012, Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms, Genes Chromosomes Cancer, 51, 743, 10.1002/gcc.21960 · DOI · Paper page
- Kao, 2011, A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia, Neoplasia, 13, 1035, 10.1593/neo.111192 · DOI
- Nicholson, 2012, Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia, Genes Chromosomes Cancer, 51, 250, 10.1002/gcc.20949 · DOI
- Saito, 2012, Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia, Leuk. Res., 36, 1009, 10.1016/j.leukres.2012.04.018 · DOI
- Schnittger, 2012, Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myeloproliferative/myelodysplastic disorders: an analysis of 636 cases, Haematologica, 10.3324/haematol.2012.065375 · doi:10.3324/haematol.2012.065375
- Shiba, 2010, CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome, Leukemia, 24, 1090, 10.1038/leu.2010.49 · doi:10.1038/leu.2010.49
- Sanada, 2009, Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms, Nature, 460, 904, 10.1038/nature08240 · DOI · Paper page
- Grand, 2009, Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms, Blood, 113, 6182, 10.1182/blood-2008-12-194548 · DOI · Paper page
- Bandi, 2009, Study Alliance Leukemias, E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease, Blood, 114, 4197, 10.1182/blood-2008-12-190934 · DOI
- Liu, 2012, Molecular targets for the treatment of juvenile myelomonocytic leukemia, Adv. Hematol., 2012, 308252, 10.1155/2012/308252 · DOI
- Mao, 2010, As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia, Proc. Natl. Acad. Sci. U.S.A., 107, 21683, 10.1073/pnas.1016311108 · DOI
- Makishima, 2012, CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors, Leukemia, 26, 1547, 10.1038/leu.2012.7 · doi:10.1038/leu.2012.7
- Loh, 2010, Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia, Hematol. Am. Soc. Hematol. Educ. Program., 2010, 357, 10.1182/asheducation-2010.1.357 · DOI
- Tan, 2010, CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases, PLoS One, 5, e8972, 10.1371/journal.pone.0008972 · DOI
- Li, 2007, Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function, PLoS Biol., 5, e35, 10.1371/journal.pbio.0050035 · DOI
- Ferron, 2010, Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling, Cell Stem Cell, 7, 367, 10.1016/j.stem.2010.06.021 · DOI
- Doniz-Padilla, 2011, Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population, Lupus, 20, 628, 10.1177/0961203310394896 · DOI
- Yokoi, 2002, Cblb is a major susceptibility gene for rat type 1 diabetes mellitus, Nat. Genet., 31, 391, 10.1038/ng927 · DOI · Paper page
- Yokoi, 2007, Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat, Diabetes, 56, 506, 10.2337/db06-1027 · DOI
- Singh, 2007, A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 104, 5413, 10.1073/pnas.0700809104 · DOI
200 of 210 shown
Cited by
Cellular signalling by primary cilia in development, organ function and disease
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B., & Christensen, S. T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0116-9 · Cited by 845
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
Schrock, A. B., Frampton, G. M., Suh, J., Chalmers, Z. R., Rosenzweig, M., Erlich, R. L., Halmos, B., Goldman, J., Forde, P., Leuenberger, K., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.004 · Cited by 384
Ohoka, N., Okuhira, K., Ito, M., Nagai, K., Shibata, N., Hattori, T., Ujikawa, O., Shimokawa, K., Sano, O., Koyama, R., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768853 · Cited by 240
“Although we focused on the proteasomal degradation of target proteins by SNIPER-mediated forced ubiquitylation in this study, ubiquitylation plays a role in a variety of cellular processes, such as autophagy (36), DNA repair (37), generation of peroxisome (38), and sorting membrane proteins in recycling endosomes (39).”
BackgroundPrimary cilia and ciliary signaling pathways in aging and age-related brain disorders
Ma, R., Kutchy, N. A., Chen, L., Meigs, D. D., & Hu, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105607 · Cited by 114
Targeting SALL4 by entinostat in lung cancer
Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12251 · Cited by 41
Metadata
- Authors
- Mohapatra, B., Ahmad, G., Nadeau, S., Zutshi, N., An, W., Scheffe, S., Dong, L., Feng, D., Goetz, B., Arya, P., Bailey, T. A., Palermo, N., Borgstahl, G. E. O., Natarajan, A., Raja, S. M., Naramura, M., Band, V., & Band, H.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 1833
- Issue
- 1
- Pages
- 122-139
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2096483233
- Cited by
- 215
- References
- 8
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
- Funders
- NIH (CA87986, CA105489, CA99163, CA116552, CA96844, CA144027)
- NCI (5U01CA151806-02)
- Department of Defense (W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171)
- UNMC
- NCI Institutional Cancer Biology Training Grant (CA009476)
- China Scholarship Council
- China Medical University Shenyang, China
- Susan G. Komen Foundation
- UNMC Diversity Fund
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.